Replies to post #3435 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

It’s a nominal slip from “2H” to “4Q.” But most experienced investors know that the two are generally synonymous.

In any event, the date that matters is when GTC submits the BLA. The old guidance was a submission at the end of 2007 and that hasn’t formally changed—yet. However, it’s obvious that they won’t be able to submit in 2007 if the data analysis is not done until late in the year. Hence, I expect the BLA-submission guidance to slip to early 2008.